English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha, China; Department of Oncology, Second Xiangya Hospital, Central South University, Changsha, China; Department of Radiation Oncology, Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, Changsha, China Contributions: (I) Conception and design: X Zhu, M Xue; (II) Administrative support: M Xue; (III) Provision of study materials or patients: X Zhu, S Yan; (IV) Collection and assembly of data: S Yan, F Xiao; (V) Data analysis and interpretation: F Xiao; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Min Xue, MD. Department of Gynecology, the Third Xiangya Hospital of Central South University,138 Tongzipo Rd. Changsha 410013, China. Email: xuemin1234@126.com.

PLGA nanoparticles delivering CPT-11 combined with focused ultrasound inhibit platinum resistant ovarian cancer